Icagen being Phase II trial of Senicapoc in Allergic Asthma

Icagen have initiated a Phase II clinical trial of KCa3.1 potassium ion channel blocker senicapoc in patients with allergic asthma.

Columbia Laboratories report Phase II results of lidocaine in vaginal dryness

Columbia Laboratories’ vaginally-administered lidocaine has demonstrated efficacy in the treatment of vaginal dryness through dysmenorrhea. although did not meet primary endpoint

Anesiva insitate Phase II trual of Adlea in Arthroscopic Shoulder Surgery

Anesiva have begun a Phase II clinical trial of Adlea, the company’s long-acting capsaicin product in for the management of acute pain in patients undergoing arthroscopic shoulder surgery involving rotator cuff repair.

UCB announce Phase IIa data on lacosamide for fibromyalgia

Data announced today by UCB  show its Voltage-gated sodium channel/Collapsin-response mediator protein 2 inhibitor lacosamide to demonstrate efficacy in fibromyalgia syndrome. UCB will decide by the end of 2008 whether to start Phase IIb trials after further analyzing the results

Phase II trials of Adlea in post orthopedic surgery pain to take place in South Korea

Anesiva to begin Phase II trial of Capsaicin drug Adlea for use in the treatment of post orthopedic surgery pain.